You are here: Industry Insights > API

News List

Supply chain automation and traceability in lifesciences sector expresspharma
December 02, 2021
Global supply chains are complex and interconnected as manufacturers are dependent on other nations, especially developing countries, for procurement of active components, API or any other raw materials that go into the manufacturing of drugs...
API supply chain needs to address future challenges arising from China situation: CPhI Worldwide panel CPhIonline
October 27, 2021
The COVID-19? pandemic has exposed weaknesses in the complex supply chain for active pharmaceutical ingredients (APIs) and the sector needs to address the challenges of rising production costs in China...
UK Regulators Recall Batches of “Sartan” Drug for Azido Impurities americanpharmaceuticalreview
August 13, 2021
The UK Medicines and Healthcare products Agency (MHRA) is recalling 25 batches of irbesartan-containing products as a precautionary measure due to contamination with an azido impurity, which the agency says has mutagenic potential.
India lags behind in terms of commercially-oriented innovation, R&D and discovery of drug modules expresspharma
August 13, 2021
Established in 1977 by G V Masurkar, ENTOD is one of the fastest growing pharmaceutical companies in the Ophthalmic ENT segment in different markets around the world, with over forty years of specialised expertise in product development and manufacturing.
Almac, PILA PHARMA Enter API Manufacturing Pact contractpharma
August 12, 2021
Almac will manufacture XEN-D0501, a highly selective and very potent small molecule TRPV1 antagonist for ongoing type 2 diabetes clinical studies.
Global API CDMO market to value almost $140bn by 2028 europeanpharmaceuticalreview
August 06, 2021
Market research suggests the Asia Pacific region could soon overtake Europe and North America in the active pharmaceutical ingredient (API) contract development and manufacturing organisation (CDMO) market.
Government imports APIs worth Rs 28,529 crores in FY2020-21 expresspharma
August 05, 2021
The size of the API and Intermediates market in India is estimated to be Rs 96,000 crores in FY 2019-20.
Not independent, but more inter-dependent than ever before expresspharma
August 04, 2021
As India's tryst with destiny and disease continues, our identity as citizens of the same planet connects us all, held ransom by the same virus.
Biden Administration to support resilience of US pharma supply chain europeanpharmaceuticalreview
August 03, 2021
US President announces $60 million in funding to support domestic API production and a consortium to onshore essential medicine manufacturing.
Achieving Aatmanirbharta in APIs: Are we on the right track? expresspharma
August 03, 2021
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats.